PGHHNSEProcter & Gamble Hygiene and Health Care Limited· Personal ProductsHighNeutral
Announced Wed, 30 Jul, 2025 · 13:22 IST

Procter & Gamble Hygiene and Health Care Limited has informed the Exchange regarding Board meeting held on July 30, 2025.

PGHH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+5.7%Reaction day
₹13117.00
prior close
₹13348.00
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.3%+5.4% vs market
Personal Care peers, median of 12sector+0.7%+5.0% vs sector

On the reaction day the stock moved 5.4 pts more than Nifty Microcap 250 and 5.0 pts more than its Personal Care peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+7.1
10m
+3.5
15m
+4.9
30m
+2.9
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+5.7+0.3+5.4+0.7+5.0
Next day
+4.8-0.4+5.2+2.1+2.8
2d
+4.4-2.0+6.4+1.9+2.5
3d
+3.8-1.5+5.3+1.4+2.4
4d
+1.9-1.8+3.7+0.1+1.8
5d
+0.6-2.9+3.5-0.8+1.4
1w
+0.6-4.0+4.6-1.6+2.2
15d
+2.2-1.1+3.2+0.7+1.4
1m
+1.0-3.1+4.1+2.1-1.0
2m
+7.7-4.8+12.5-3.9+11.6
3m
+2.2-0.7+2.9-3.3+5.6
UpDownMarket · Nifty Microcap 250Sector · Personal Care peers, median of 12Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Procter & Gamble Hygiene and Health Care Limited (PGHH) has informed the stock exchanges that its Board of Directors met on July 30, 2025 and approved the unaudited financial results for the quarter ended June 30, 2025 (Q1 FY26). The board meeting lasted roughly 31 minutes (12:44 p.m. to 1:15 p.m.). Along with the financial results, the company also submitted the Limited Review Report from its statutory auditors. The actual financial figures have been filed separately as enclosures and are not included in this notice.

Likely market impact

This is a routine regulatory filing confirming that Q1 FY26 results have been approved by the board; it has no direct impact on the stock price, but the actual numbers (revenue, profit, margins) once disclosed separately will determine market reaction.